We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Gelion Plc | GELN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.00 | 6.25% | 17.00 | 16:35:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 16.00 | 16.00 | 16.00 | 17.00 | 16.00 |
| Industry Sector |
|---|
| ALTERNATIVE ENERGY |
| Top Posts |
|---|
Posted at 19/12/2024 12:51 by charleysays You’d think there could be some synergy between GELN and CPX. Only 8m mcap on CPX so some way to go. |
Posted at 05/4/2024 09:34 by citys2874 it's a happy Friday. Good morning all...lovely breakout for GELN and SAAS in early trading....expect more people coming and we may even see these number 1 and number 2 percentage gainers today with some volume |
Posted at 15/8/2023 06:39 by 74tom What shysters;"Revenues for the year are expected to be £2.0m ahead of current guidance of £1.7m." Oh GELN has revenue, now that wasn't something I was aware of... Finds last Fincapp broker report; "Similar to last year, there was no revenue for the period as Gelion only recognises R&D tax incentive income at year-end (June). Australia provides a 43.5% tax refundable offset for eligible research and development expenditure, which for FY23 we expect to amount to a R&D tax benefit of £1.7m, flat on last year." Oh. So they've reclaimed more R&D credit than forecast, not disclosed that in the trading update and claimed 'revenue' is ahead of expectations. Anyone reading the update will almost certainly believe that revenue is from selling batteries, so it's very misleading IMO. |
Posted at 03/7/2022 10:26 by simongn Some info for those that may not have seen it:and . . . "Our strategy Company growth will be built around two central strategies: · Manufacturing partnerships in key markets to make and distribute our patented non-flow, zinc-bromide Endure battery; and · Licensing agreements that access our patented advanced lithium-silicon and lithium-sulfur performance additives to enhance lithium-ion mobile energy storage." |
Posted at 30/1/2022 12:44 by mjneish Good to be back. I've been out of the stock market for a very long time, but have regretted not returning a few years ago.Tim McCarthy seems to have continued his illustrious value-destroying career at Immupharma, while Richard Palmer seems to have vanished off the face of the Earth. As for GELN, I wouldn't even know where to start, so I'd rather not say anything at this time! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
